New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 21, 2012
09:25 EDTRHT, NKE, CEMI, HALO, PFE, RIMM, WAG, TSPTOn The Fly: Pre-market Movers
HIGHER AFTER EARNINGS: Red Hat (RHT), up 5.4%... Nike (NKE), up 3%... ALSO HIGHER: Chembio Diagnostics (CEMI), up 20.7% after receiving FDA approval for its rapid HIV test... Halozyme (HALO), up 17.4% after entering a development collaboration with Pfizer (PFE)... Ameristar Casinos (ASCA), up 17% after agreeing to be acquired by Pinnacle Entertainment (PNK) for $26.50 per share... LOWER AFTER EARNINGS: Research in Motion (RIMM), down 16.3%... Walgreen (WAG), down 1.7%... ALSO LOWER: Transcept (TSPT), down 14.7% after Phase 2 trial of OCD drug misses primary endpoint.
News For RHT;NKE;CEMI;HALO;PFE;RIMM;WAG;TSPT From The Last 14 Days
Check below for free stories on RHT;NKE;CEMI;HALO;PFE;RIMM;WAG;TSPT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
September 18, 2014
16:05 EDTRHTRed Hat reports Q2 EPS 41c, consensus 38c
Reports Q2 revenue $445.9M, consensus $437.13M.
15:15 EDTRHTNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Oracle (ORCL), consensus 64c; Red Hat (RHT), consensus 38c; TIBCO Software (TIBX), consensus 18c.
15:00 EDTRHTRed Hat September 60 straddle priced for 6.7% move into Q2
14:21 EDTRHTRed Hat technical comments before earnings
Subscribe for More Information
11:55 EDTWAGRite Aid falls as drugstore chain trims FY15 view
Subscribe for More Information
09:33 EDTNKENike mentioned positively at OTR Global
Subscribe for More Information
09:22 EDTNKEBack to school season healthy for footwear, says Sterne Agee
Subscribe for More Information
09:05 EDTHALOHalozyme's pancreatic cancer candidate clinical trial approved by FDA to resume
Halozyme announced that the FDA has removed the clinical hold on patient enrollment and dosing of PEGPH20 in SWOG's ongoing Phase 1b/2 clinical trial. The trial is designed to evaluate Halozyme's investigational drug PEGPH20 in combination with modified FOLFIRINOX chemotherapy in patients with metastatic pancreatic adenocarcinoma. The study will resume under a revised protocol.
08:02 EDTRHTRed Hat to acquire FeedHenry for EUR63.5M in cash
Red Hat announced that it has signed a definitive agreement to acquire FeedHenry, an enterprise mobile application platform provider. FeedHenry expands Red Hatís broad portfolio of application development, integration, and Platform-as-a-Service solutions, enabling Red Hat to support mobile application development in public and private environments. Red Hat has agreed to acquire FeedHenry, a privately held company, for approximately EUR 63.5M in cash, subject to certain adjustments at closing. The transaction is expected to close in 3Q15, subject to customary closing conditions.
07:26 EDTNKEGartner: Smartwatch market ready to expand, poised for takeoff, DigiTimes says
Subscribe for More Information
September 17, 2014
13:34 EDTNKENike September weekly volatility elevated into Q1 and outlook
Nike September weekly option implied volatility is at 34, October is at 22, January is at 19; compared to its 26-week average of 21 according to Track Data, suggesting large near term price movement into the expected release of Q1 results on September 25.
12:01 EDTNKENike suspends contract with Adrian Peterson
Subscribe for More Information
10:00 EDTNKEOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:58 EDTRHTRed Hat October volatility elevated into Q2 and outlook
Red Hat September call option implied volatility is at 92, October is at 36, December is at 29; compared to its 26-week average of 30 according to Track Data, suggesting large near term price movement into the expected release of Q2 results on September 18.
07:43 EDTPFEBofA/Merrill to hold a conference
Subscribe for More Information
07:30 EDTNKENike September weekly volatility elevated into Q1 and outlook
Subscribe for More Information
September 16, 2014
16:34 EDTNKENike assumed with a Neutral at Piper Jaffray
Target $77.
11:51 EDTPFEOECD looks to close tax loopholes with new proposals
Subscribe for More Information
08:12 EDTWAGWalgreen files S-4, prospectus for strategic transaction with Alliance Boots
Subscribe for More Information
07:19 EDTPFECompanies' share buybacks at fasttest clip since 2007, WSJ reports
Companies are buying back their own shares at its fastest pace since the financial crisis to fuel a stock rally, reports the Wall Street Journal. According to Birinyi Associates, companies have bought back $338.3B of stock in 1H14, the most since 2007. Citing an analysis by Barclays, companies with the largest buyback programs by dollar value have outperformed the broader market by 20% since 2008. Reference Link
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use